Search Results 91-100 of 2153 for 구글찌라시 り 16242136 り텔@adtopkingりり구글콘솔りりり텔@adtopkingりりり키워드마케팅りりり

  1. Faculty - Mayo Clinic Research

    The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...

  2. A Study to Evaluate Chest Pain Risk Stratification Using HEART Pathway in Community Emergency Departments - Mayo Clinic

    About this study. The objectives of this study are to evaluate utilization of chest pain risk stratification tools in a community hospital emergency ...

  3. Comparison of Short and Long-Term Outcomes between Surgical Septal Myectomy and Alcohol Septal Ablation - Mayo Clinic

    About this study. The standard of care for obstructive hypertrophic cardiomyopathy (HCM) refractory to medical therapy is surgical septal myectomy.

  4. Teaching and Learning - Curriculum - Mayo Clinic College of Medicine & Science

    Teaching and learning curriculum for the PGY-2 Clinical Pharmacogenomics Residency at Mayo Clinic in Rochester, Minnesota.

  5. Collaborators - Genome Function, Stability and Nuclear Organization in Cancer: Veronica Rodriguez-Bravo - Mayo Clinic Research

    Dr. Veronica Rodriguez-Bravo engages in research collaborations with other Mayo Clinic investigators.

  6. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

    Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...

  7. Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Drugs used in chemotherapy, ...

  8. MC200404, Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

    However, TAS-102 is FDA approved for treatment of metastatic colorectal cancer. The FDA has allowed the use of this combination in this research study.

  9. Contact - Mayo Clinic Research

    Researchers can contact the Center for Cell Signaling in Gastroenterology at Mayo Clinic about digestive diseases research, core services or collaborations.

  10. A Study to Collect Ovarian Tissue from Girls Undergoing Fertility-preserving Cryopreservation - Mayo Clinic

    The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer patients ...